These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 19334069

  • 21. T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta.
    Durelli L, Conti L, Clerico M, Boselli D, Contessa G, Ripellino P, Ferrero B, Eid P, Novelli F.
    Ann Neurol; 2009 May; 65(5):499-509. PubMed ID: 19475668
    [Abstract] [Full Text] [Related]

  • 22. Insights into the molecular pathogenesis of progression in multiple sclerosis: potential implications for future therapies.
    Imitola J, Chitnis T, Khoury SJ.
    Arch Neurol; 2006 Jan; 63(1):25-33. PubMed ID: 16401734
    [Abstract] [Full Text] [Related]

  • 23. Normal plasma antithrombin activity in patients with relapsing-remitting and secondary progressive multiple sclerosis.
    Campos-de-Magalhães M, de Almeida AJ, Papaiz-Alvarenga RM, Gadelha T, Morais-de-Sá CA, Alves-Leon SV.
    Clin Neurol Neurosurg; 2009 Jun; 111(5):407-11. PubMed ID: 19168277
    [Abstract] [Full Text] [Related]

  • 24. Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis.
    Teunissen CE, Iacobaeus E, Khademi M, Brundin L, Norgren N, Koel-Simmelink MJ, Schepens M, Bouwman F, Twaalfhoven HA, Blom HJ, Jakobs C, Dijkstra CD.
    Neurology; 2009 Apr 14; 72(15):1322-9. PubMed ID: 19365053
    [Abstract] [Full Text] [Related]

  • 25. Role of B cells in pathogenesis of multiple sclerosis.
    Nikbin B, Bonab MM, Khosravi F, Talebian F.
    Int Rev Neurobiol; 2007 Apr 14; 79():13-42. PubMed ID: 17531836
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis.
    Huang YH, Zozulya AL, Weidenfeller C, Metz I, Buck D, Toyka KV, Brück W, Wiendl H.
    Ann Neurol; 2009 Aug 14; 66(2):171-83. PubMed ID: 19705413
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosis.
    Weiner HL.
    J Neurol; 2008 Mar 14; 255 Suppl 1():3-11. PubMed ID: 18317671
    [Abstract] [Full Text] [Related]

  • 31. The destructive alliance: interactions of leukocytes, cerebral endothelial cells, and the immune cascade in pathogenesis of multiple sclerosis.
    Minagar A, Carpenter A, Alexander JS.
    Int Rev Neurobiol; 2007 Mar 14; 79():1-11. PubMed ID: 17531835
    [Abstract] [Full Text] [Related]

  • 32. Persistent activation of microglia is associated with neuronal dysfunction of callosal projecting pathways and multiple sclerosis-like lesions in relapsing--remitting experimental autoimmune encephalomyelitis.
    Rasmussen S, Wang Y, Kivisäkk P, Bronson RT, Meyer M, Imitola J, Khoury SJ.
    Brain; 2007 Nov 14; 130(Pt 11):2816-29. PubMed ID: 17890734
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Immunology of multiple sclerosis.
    Sospedra M, Martin R.
    Annu Rev Immunol; 2005 Nov 14; 23():683-747. PubMed ID: 15771584
    [Abstract] [Full Text] [Related]

  • 35. [New therapeutic approaches in progressive multiple sclerosis].
    Faissner S, Gold R.
    Fortschr Neurol Psychiatr; 2019 Nov 14; 87(11):653-671. PubMed ID: 31783427
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Clinical response to interferon-beta-1a may be linked to low baseline circulating BDCA1 myeloid dendritic cells Differential role of circulating dendritic cells and CD4+ regulatory T-cells in relapsing-remitting multiple sclerosis: a 1-year longitudinal study.
    de Andrés C, Aristimuño C, Bartolomé M, de Las Heras V, Martínez-Ginés ML, Arroyo R, Fernández-Cruz E, Sánchez-Ramón S.
    J Neuroimmunol; 2009 Jul 25; 212(1-2):112-20. PubMed ID: 19446889
    [Abstract] [Full Text] [Related]

  • 38. Characterizing the mechanisms of progression in multiple sclerosis: evidence and new hypotheses for future directions.
    Frohman EM, Filippi M, Stuve O, Waxman SG, Corboy J, Phillips JT, Lucchinetti C, Wilken J, Karandikar N, Hemmer B, Monson N, De Keyser J, Hartung H, Steinman L, Oksenberg JR, Cree BA, Hauser S, Racke MK.
    Arch Neurol; 2005 Sep 25; 62(9):1345-56. PubMed ID: 16157741
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.